[go: up one dir, main page]

WO2022264166A1 - Process for the preparation of pure salcaprozate sodium - Google Patents

Process for the preparation of pure salcaprozate sodium Download PDF

Info

Publication number
WO2022264166A1
WO2022264166A1 PCT/IN2022/050541 IN2022050541W WO2022264166A1 WO 2022264166 A1 WO2022264166 A1 WO 2022264166A1 IN 2022050541 W IN2022050541 W IN 2022050541W WO 2022264166 A1 WO2022264166 A1 WO 2022264166A1
Authority
WO
WIPO (PCT)
Prior art keywords
salcaprozate
sodium
acid
preparation
pure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2022/050541
Other languages
French (fr)
Inventor
Sureshbabu JAYACHANDRA
Ramakoteswara Rao Jetti
Nitin Ashok Shimpi
Nageswararao Nalajala
Satyanarayana Raavi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Laboratories Ltd
Original Assignee
Mylan Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mylan Laboratories Ltd filed Critical Mylan Laboratories Ltd
Publication of WO2022264166A1 publication Critical patent/WO2022264166A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/22Separation; Purification; Stabilisation; Use of additives
    • C07C231/24Separation; Purification

Definitions

  • the present invention relates to process for the preparation of pure Salcaprozate sodium free of color impurity.
  • Salcaprozate sodium is chemically known as N-(8-[2-hydroxybenzoyl]-amino) caprylic acid sodium and its represented by Formula 1. Which is also known as SNAC sodium.
  • US patent 7544833 discloses avoiding or reducing the production of a color impurity therein comprising the step of hydrolyzing 2,4-dioxo-l,3-benzoxazinyloctanoic acid ethyl ester by admixing 2,4-dioxo-l,3-benzoxazinyloctanoic acid ethyl ester with sodium hydroxide, water, and a member selected from the group consisting of ethylenediamine tetra acetic acid (EDTA), ascorbic acid, NaHSCE, and triphenylpho sphine .
  • EDTA ethylenediamine tetra acetic acid
  • the main aspect of the present invention relates to process for the preparation of pure Salcaprozate sodium free of color impurity.
  • the present invention relates to process for the preparation of Salcaprozate acid comprising the steps of: a) hydrolyzing 2,4-dioxo-l,3-benzoxazinyloctanoic acid ethyl ester in the presence of sodium hydroxide, water and reducing agent, and b) isolating white Salcaprozate acid.
  • the present invention provides a process for the preparation of pure Salcaprozate sodium free of color impurity.
  • the present invention provides a process for the preparation of Salcaprozate acid comprising the steps of: a) hydrolyzing 2,4-dioxo-l,3-benzoxazinyloctanoic acid ethyl ester in the presence of sodium hydroxide, water and reducing agent, and b) isolating white Salcaprozate acid.
  • hydrolysis of 2,4-dioxo-l,3- benzoxazinyloctanoic acid ethyl ester may be carried out using water, sodium hydroxide and catalytic amount of reducing agent and the reaction mass may be heated to about 70-100°C for 2-4 hours. After completion of the reaction, the reaction mass may be cooled to room temperature, followed by adjusting the pH to 4.0 to 4.5 with hydrochloric acid and maintained for 2 to 20 hours. The resultant solid may be filtered to obtain white Salcaprozate acid.
  • reducing agents are selected from Sodium borohydride, sodium sulfite or Zinc powder.
  • hydrolysis of 2,4-dioxo-l,3- benzoxazinyloctanoic acid ethyl ester may be carried out using water which may be degassed with vacuum followed by releasing of vacuum with Nitrogen purging and sodium hydroxide.
  • the reaction mass may be heated to about 70-100°C for 2-4 hours. After completion of the reaction, the reaction mass may be cooled to room temperature, followed by adjusting the pH to 4.0 to 4.5 with hydrochloric acid and stirred for 2 to 4 hours.
  • the resultant solid may be filtered to obtain white Salcaprozate acid.
  • hydrolysis of 2,4-dioxo-l,3- benzoxazinyloctanoic acid ethyl ester may be carried out using ethanol, sodium hydroxide and the reaction mass may be heated to about 70-90°C, maintained for 2-12 hours. Water may be added to the reaction mass followed by adjusting the pH to 4.0 to 4.5 with hydrochloric acid and maintained for 2 to 4 hours. The resultant solid may be filtered to obtain white Salcaprozate acid.
  • present invention provides a process for the preparation of Salcaprozate sodium comprising the steps of: a) contacting white Salcaprozate acid with sodium hydroxide in ethanol, b) adding an anti-solvent, and c) isolating Salcaprozate sodium.
  • white Salcaprozate acid reacts with sodium hydroxide in ethanol at about 30°C and the reaction mass may be maintained for 45- 60 minutes. After completion of reaction, the reaction mass may be filtered and washed with ethanol. To the resultant filtrate, an anti-solvent such as di-isopropyl ether may be added and maintained for about 3 hours at room temperature. The resultant solid may be filtered to obtain pure Salcaprozate sodium.
  • the present invention encompasses reverse addition of resultant filtrate into the anti-solvent such as di-isopropyl ether and isolation of Salcaprozate sodium.
  • Salcaprozate sodium is used as an excipient in the preparation of pharmaceutical compositions along with drug substance for increasing the solubility.
  • the pure Salcaprozate sodium prepared according to the present invention is used as an excipient in the preparation of Semaglutide.
  • Salcaprozate Acid is white to off-white and free from pink shade.
  • Salcaprozate Acid 25 g
  • Ethanol 88 mL
  • Temperature was raised to 30°C and then sodium hydroxide solution (3.5 lg of sodium hydroxide dissolved in 10 ml of water) was added to the reaction mass.
  • Reaction mass was stirred for 45 minutes and then filtered followed by washing of Ethanol (12.5 mL).
  • Di-isopropyl ether 325 mL was added and stirred for 3 hours at room temperature. Finally filtered and dried under vacuum to get Salcaprozate sodium (25g).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The present invention relates to process for the preparation of pure Salcaprozate sodium free of color impurities.

Description

PROCESS FOR THE PREPARATION OF PURE SALCAPROZATE SODIUM
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims the benefit of the earlier filing date of Indian Provisional Patent Application No. IN 202141026463 filed on June 14, 2021.
FIELD OF THE INVENTION
The present invention relates to process for the preparation of pure Salcaprozate sodium free of color impurity.
BACKGROUND OF THE INVENTION
Salcaprozate sodium is chemically known as N-(8-[2-hydroxybenzoyl]-amino) caprylic acid sodium and its represented by Formula 1. Which is also known as SNAC sodium.
Figure imgf000002_0001
Formula 1
The preparation of SNAC sodium may lead to product which includes color-bodies. US patent 7544833 discloses avoiding or reducing the production of a color impurity therein comprising the step of hydrolyzing 2,4-dioxo-l,3-benzoxazinyloctanoic acid ethyl ester by admixing 2,4-dioxo-l,3-benzoxazinyloctanoic acid ethyl ester with sodium hydroxide, water, and a member selected from the group consisting of ethylenediamine tetra acetic acid (EDTA), ascorbic acid, NaHSCE, and triphenylpho sphine .
SUMMARY OF THE INVENTION
The main aspect of the present invention relates to process for the preparation of pure Salcaprozate sodium free of color impurity.
In one aspect, the present invention relates to process for the preparation of Salcaprozate acid comprising the steps of: a) hydrolyzing 2,4-dioxo-l,3-benzoxazinyloctanoic acid ethyl ester in the presence of sodium hydroxide, water and reducing agent, and b) isolating white Salcaprozate acid.
DETAILED DESCRIPTION OF THE INVENTION
The present invention provides a process for the preparation of pure Salcaprozate sodium free of color impurity.
In one embodiment, the present invention provides a process for the preparation of Salcaprozate acid comprising the steps of: a) hydrolyzing 2,4-dioxo-l,3-benzoxazinyloctanoic acid ethyl ester in the presence of sodium hydroxide, water and reducing agent, and b) isolating white Salcaprozate acid.
Within the context of this embodiment, hydrolysis of 2,4-dioxo-l,3- benzoxazinyloctanoic acid ethyl ester may be carried out using water, sodium hydroxide and catalytic amount of reducing agent and the reaction mass may be heated to about 70-100°C for 2-4 hours. After completion of the reaction, the reaction mass may be cooled to room temperature, followed by adjusting the pH to 4.0 to 4.5 with hydrochloric acid and maintained for 2 to 20 hours. The resultant solid may be filtered to obtain white Salcaprozate acid.
Within the context of this embodiment, reducing agents are selected from Sodium borohydride, sodium sulfite or Zinc powder.
Within the context of this embodiment, hydrolysis of 2,4-dioxo-l,3- benzoxazinyloctanoic acid ethyl ester may be carried out using water which may be degassed with vacuum followed by releasing of vacuum with Nitrogen purging and sodium hydroxide. The reaction mass may be heated to about 70-100°C for 2-4 hours. After completion of the reaction, the reaction mass may be cooled to room temperature, followed by adjusting the pH to 4.0 to 4.5 with hydrochloric acid and stirred for 2 to 4 hours. The resultant solid may be filtered to obtain white Salcaprozate acid.
Within the context of this embodiment, hydrolysis of 2,4-dioxo-l,3- benzoxazinyloctanoic acid ethyl ester may be carried out using ethanol, sodium hydroxide and the reaction mass may be heated to about 70-90°C, maintained for 2-12 hours. Water may be added to the reaction mass followed by adjusting the pH to 4.0 to 4.5 with hydrochloric acid and maintained for 2 to 4 hours. The resultant solid may be filtered to obtain white Salcaprozate acid.
In another embodiment, present invention provides a process for the preparation of Salcaprozate sodium comprising the steps of: a) contacting white Salcaprozate acid with sodium hydroxide in ethanol, b) adding an anti-solvent, and c) isolating Salcaprozate sodium.
Within the context of this embodiment, white Salcaprozate acid reacts with sodium hydroxide in ethanol at about 30°C and the reaction mass may be maintained for 45- 60 minutes. After completion of reaction, the reaction mass may be filtered and washed with ethanol. To the resultant filtrate, an anti-solvent such as di-isopropyl ether may be added and maintained for about 3 hours at room temperature. The resultant solid may be filtered to obtain pure Salcaprozate sodium.
Within the context of this embodiment, the present invention encompasses reverse addition of resultant filtrate into the anti-solvent such as di-isopropyl ether and isolation of Salcaprozate sodium.
Salcaprozate sodium is used as an excipient in the preparation of pharmaceutical compositions along with drug substance for increasing the solubility.
The pure Salcaprozate sodium prepared according to the present invention is used as an excipient in the preparation of Semaglutide.
Advantages
1. Using reducing agents such as Sodium sulfite, Zinc or Sodium borohydride, the color of obtained Salcaprozate Acid is white to off-white and free from pink shade.
2. Existing reported literature process of Salcaprozate sodium involves usage of n-Heptane by which the filtration of material is very slow. The use of di-isopropyl ether provides good crystalline material which is filtered very fast and ultimately reduces overhead cost. Reported literature (US7544833) shows usage of Acetone along with NaHS03. The pink color is because of oxidation and it is observed that when the reaction is carried out with nitrogen purging there is reduction in the pink color, however using sodium sulfite, Zinc and other reagents like sodium borohydride the color of the Salcaprozate-Acid is white even without nitrogen.
Comparison of Sodium sulfite and sodium bisulfite.
Figure imgf000005_0001
In view of the above description and the examples below, one of the ordinary skills in the art will be able to practice the invention as claimed without undue experimentation. The foregoing will be better understood with reference to the following examples that detail certain procedures for the preparation of molecules according to the present invention. All references made to these examples are for the purposes of illustration. The following examples should not be considered exhaustive, but merely illustrative of only a few of the many aspects and embodiments contemplated by the present disclosure.
EXAMPLES:
Example 1: Preparation of Salcaprozate-Acid
Water (140 mL) was taken into to the flask sodium hydroxide (16.8g) was charged to it (temperature raised to 50°C). Sodium sulfite (1.4 g, NaiSCL) was charged to reaction mass and maintained temperature 50-60°C for 1 hour. Reaction mass was cooled to 40-45°C. Ethyl, 8-(2,4-dioxo-2H-l,3-benzoxazin- 3(4H)-yl) octanoate (35 g) was charged to the solution and heated to 90-94°C. Reaction mass was maintained for 2 hours and cooled to 27°C. pH of the reaction mass was adjusted to 4.1 with Hydrochloric acid (46g). Reaction mass was stirred for 16 hours at room temperature, filtered the reaction mass, washed with water (105 mL). Finally, material was dried and obtained 28g of white material of Salcaprozate Acid.
Example 2: Preparation of Salcaprozate-Acid
Water (40 mL) and Zinc (0.5g) was taken into the flask and heated to 50°C. After heating for 30 minutes, it was cooled to 40°C. sodium hydroxide (9.6g) was charged to it (temperature raised to 45°C). Reaction mass temperature was reduced to 29°C and Ethyl, 8-(2,4-dioxo-2H-l,3-benzoxazin-3(4H)-yl) octanoate (20 g) is charged and heated to 93-94°C. Water (40mL) was added to reaction mass and maintained for 2 hours; reaction mass was cooled to 40°C. Reaction mass was filtered, and pH of the filtrate was adjusted to 4.3 with Hydrochloric acid (30g). Reaction mass was stirred for 2 hours at room temperature, filtered, and washed with water (60mL). Finally, material was dried and obtained 15.8g of white material of Salcaprozate Acid.
Example 3: Preparation of Salcaprozate-Acid
Water (80 mL) was taken into the flask sodium hydroxide (9.6g) was charged to it (temperature raised to 52°C). Sodium borohydride (0.1 g, NaBH4) was charged to reaction mass and maintained temperature for 1 hour at 50-52°C. Reaction mass temperature was reduced to 30-35°C and Ethyl, 8-(2,4-dioxo-2H-l,3- benzoxazin-3(4H)-yl) octanoate (20 g) was charged and heated to 92-94°C. Reaction mass was maintained for 2 hours and cooled to 27°C. pH of the reaction mass was adjusted to 4.3 with Hydrochloric acid. Reaction mass was stirred for 4 hours at room temperature, filtered, and washed with water (60 mL). Finally, material was dried and obtained 16g of white material of Salcaprozate Acid.
Example 4: Preparation of Salcaprozate-Acid
Water (100 mL) was into the flask. Water was degassed with vacuum followed by releasing of vacuum with Nitrogen purging. It was repeated two times and sodium hydroxide (24g) is charged to it (temperature raised to 60°C). Reaction mass was cooled to 35°C and Ethyl, 8-(2,4-dioxo-2H-l,3-benzoxazin-3(4H)-yl) octanoate (50 g) was charged and heated to 91-94°C. Reaction mass was maintained for 2 hours and cooled to 30°C and water (lOOmL) was added to the reaction mass. pH of the reaction mass was adjusted to 4.3 with Hydrochloric acid (68g). Reaction mass was raised to 50°C and stirred for 30 minutes followed by cooling to 27 °C and stirred for 3 hours at room temperature, filtered and washed with 150 ml of water. Finally, material was dried and obtained 40g of Off-white material of Salcaprozate Acid.
Example 5: Preparation of Salcaprozate acid
Ethanol (100 mL) was taken into the flask sodium hydroxide (4.8g) and Ethyl, 8- (2,4-dioxo-2H-l,3-benzoxazin-3(4H)-yl) octanoate (10 g) were charged to the flask and heated to reflux at 74-76°C. Water (20 mL) was added to it and maintained for 10 hours and cooled to 30°C and added water (lOOmL). pH of the reaction mass was adjusted to 4.12 with Hydrochloric acid (12g). Reaction mass was stirred for 2 hours at room temperature, filtered the reaction mass, washed with water (30 mL). Finally, material was dried and obtained 7.0g of Salcaprozate Acid with Off-white color (No pink tinge is observed).
Example 6: Preparation of Salcaprozate Sodium
Salcaprozate Acid (25 g) and Ethanol (88 mL) were taken into the flask. Temperature was raised to 30°C and then sodium hydroxide solution (3.5 lg of sodium hydroxide dissolved in 10 ml of water) was added to the reaction mass. Reaction mass was stirred for 45 minutes and then filtered followed by washing of Ethanol (12.5 mL). Into the filtrate of Di-isopropyl ether (325 mL) was added and stirred for 3 hours at room temperature. Finally filtered and dried under vacuum to get Salcaprozate sodium (25g).

Claims

We claim:
1. A process for the preparation of pure Salcaprozate sodium.
2. The process as claimed in claim 1, wherein the pure Salcaprozate sodium is prepared comprising the steps of: a) hydrolyzing 2,4-dioxo-l,3-benzoxazinyloctanoic acid ethyl ester in the presence of sodium hydroxide, water and reducing agent, b) isolating white Salcaprozate acid, c) contacting white Salcaprozate acid with sodium hydroxide in presence of a solvent, d) adding an anti-solvent, and e) isolating pure Salcaprozate sodium.
3. The process as claimed in claim 2, wherein the reducing agent is Sodium borohydride.
4. The process as claimed in claim 2, wherein the reducing agent is Zinc powder.
5. The process as claimed in claim 2, wherein the reducing agent is sodium sulfite.
6. The process as claimed in claim 2, wherein the solvent is selected from alcohols
7. The process as claimed in claim 2, wherein the solvent is ethanol.
8. The process as claimed in claim 2, wherein the anti-solvent is di isopropyl ether
9. The process as claimed in claim 2, wherein the pure Salcaprozate sodium is used as an excipient in the preparation of pharmaceutical compositions.
10. The process as claimed in claim 2, wherein the pure Salcaprozate sodium is used as an excipient in the preparation of Semaglutide.
PCT/IN2022/050541 2021-06-14 2022-06-13 Process for the preparation of pure salcaprozate sodium Ceased WO2022264166A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN202141026463 2021-06-14
IN202141026463 2021-06-14

Publications (1)

Publication Number Publication Date
WO2022264166A1 true WO2022264166A1 (en) 2022-12-22

Family

ID=82594930

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2022/050541 Ceased WO2022264166A1 (en) 2021-06-14 2022-06-13 Process for the preparation of pure salcaprozate sodium

Country Status (1)

Country Link
WO (1) WO2022264166A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1535625A1 (en) * 1999-04-05 2005-06-01 Emisphere Technologies, Inc. Composition containing n-(5-chlorosalicyloyl)-8-aminocaprylic acid and salmon calcitonin
US7544833B2 (en) 2006-09-07 2009-06-09 Hoffmann-La Roche Inc. Methods for producing N-(8-[2-hydroxybenzoyl]-amino) caprylic acid

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1535625A1 (en) * 1999-04-05 2005-06-01 Emisphere Technologies, Inc. Composition containing n-(5-chlorosalicyloyl)-8-aminocaprylic acid and salmon calcitonin
US7544833B2 (en) 2006-09-07 2009-06-09 Hoffmann-La Roche Inc. Methods for producing N-(8-[2-hydroxybenzoyl]-amino) caprylic acid

Similar Documents

Publication Publication Date Title
KR100979216B1 (en) Method for preparing quinoline derivative
CN111511722B (en) Method for preparing oxa-goril intermediate and composition thereof
RU2621681C2 (en) Method
WO2022264166A1 (en) Process for the preparation of pure salcaprozate sodium
US10538507B2 (en) Preparation process for high-purity dabigatran etexilate
CN106831723B (en) Improved refining method of delafloxacin
EP2088144B1 (en) Method of producing s-(-)-6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid
CN114181117A (en) Preparation method of peramivir intermediate
JP2020083892A (en) BERAPROST-314d MONOHYDRATE CRYSTALS AND METHODS FOR PREPARATION THEREOF
WO2024114710A1 (en) Method for preparing cabozantinib and intermediate thereof
CA2961819C (en) L-proline compound of sodium-glucose cotransporter 2 inhibitor, and monohydrate and crystal of l-proline compound
CN108727445B (en) Synthesis method of azithromycin impurity F
CN111018777B (en) Preparation method of dequalinium chloride
JP7623802B2 (en) Biotin and its manufacturing method, and biotin-amine salt manufacturing method
JPH0436157B2 (en)
CN114957130B (en) Purification method and application of high-purity 5-benzylidene hydantoin
US862675A (en) Orthodioxyphenylethanolamin.
CN114853692B (en) Preparation method of 2-aminothiazole
CN114369134B (en) A Lupane triterpenoid derivative meglumine salt amorphous substance and its preparation method and application
KR20140143437A (en) Compound jk12a and preparation thereof
EP4368577A1 (en) Process for the preparation of tungsten (vi) salt hydrates
CA2649032A1 (en) Narcotine purification process
CN110872322B (en) Preparation method of cefaloside acetate monohydrate and intermediate thereof
CN102702006A (en) Preparation method of 3-amino-2-ethyl nitrobenzoate
KR100749162B1 (en) Method for preparing aceclofenac amino acid salt

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22743601

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 22743601

Country of ref document: EP

Kind code of ref document: A1